David Allison

David Allison is a managing director at Westlake Village BioPartners®, a venture capital firm specializing in life sciences, since March 2023. In addition, David serves as a board member for several companies, including Recludix Pharma and Neurogastrx, Inc., where involvement includes critical committee roles. Previous positions include board memberships at Impel Pharmaceuticals, Radionetics Oncology, and Portal Instruments, among others, showcasing expertise in biopharmaceuticals and innovative medical technologies. David holds a Ph.D. in bioengineering from Rice University and a BSE in biomedical engineering from the University of Iowa.